Platelet-derived growth factor in chemotactic for fibroblasts by unknown
Platelet-derived Growth Factor Is Chemotactic for Fibroblasts
HEIKKI SEPPA, GARY GROTENDORST, SILJA SEPPA, ELLIOTT SCHIFFMANN, and GEORGE R . MARTIN
Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research, National Institutes of Health, Bethesda,
Maryland 20205. The present address of Or. H . Seppa' and Dr . S. Seppa' is the Department of Anatomy, University of Oulu, SF-90220
Oulu 22, Finland.
ABSTRACT
￿
Chemotaxis assays in modified Boyden chambers were used to detect fibroblast chemoat-
tractants in materials released from early-stage inflammatory cells, namely, mast cells, platelets, and
neutrophils . Strong attractant activity was found in substances released from platelets . This activity
was accounted for mainly by the platelet-derived growth factor (PDGF), which is released from the
platelets and which was active as a chemoattractant at 0.5-1 .0 mitogenic units/ml . The mitogenic
activity of purified PDGF, measured by [3H]thymidine incorporation, occurs at a similar concentration
range . By varying the gradient of PDGF, we demonstrated that PDGF stimulates chemotaxis rather
than random motility . Preincubation of suspensions of fibroblasts in the presence of PDGF decreased
the subsequent migration of cells to a gradient of PDGF as well as to a gradient of fibronectin, which
is also an attractant for fibroblasts . The chemotactic response of fibroblasts to PDGF was not inhibited
by hydroxyurea or azidocytidine but was inhibited by actinomycin D and cycloheximide, suggesting
that synthesis of RNA and proteins but not of DNA is required for the chemotactic response to occur .
Fibroblast growth factor, epidermal growth factor, nerve growth factor, and insulin were not chemo-
tactic for human skin fibroblasts, suggesting that the chemoattractant activity of PDGF for fibroblasts
is not a general property of growth factors and mitogens . These results suggest that PDGF could have
two functions in wound healing: to attract fibroblasts to migrate into the clot and then to induce their
proliferation .
It is well-known that, in a wound, cells invade the blood clot
in a defined sequence . Polymorphonuclear leukocytes arrive
first, followed by mononuclear leukocytes, fibroblasts, and
finally endothelial cells (1) . It is generally thought that the
phagocytic cells are attracted to materials present in the wound,
such as complement-derived peptides (2-4), products of the
clotting system (5), the fibrinolysis pathway (6, 7), or the
kallikrein-kinin system (7, 8) . Less is known about the factors
which cause fibroblasts to migrate into the wound . It has been
suggested that proliferation of these cells occurs after loss of
contact inhibition, perhaps due to a diffusible "wound hor-
mone," and that the cells subsequently fill the space free of
fibroblasts (9) .
Recent studies have shown that fibroblasts exhibit directed
migration along a concentration gradient, a process known as
chemotaxis . Using a Boyden chamber for assaying chemotaxis,
migration of fibroblasts across collagen-coated filters has been
observed in response to products ofactivated lymphocytes (10)
and macrophages (11) as well as to collagen and to peptides
produced by the enzymatic degradation ofcollagen (12) . More
recently, it has also been observed that fibroblasts are attracted
to fibronectin (13-16) and to the portion of the fibronectin
molecule which contains the cell-binding region but not to that
containing the collagen-binding region (14-16) .
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In this study we have investigated the chemotactic response
ofhuman skin fibroblasts to substances released by cells which
are present in the initial stages ofwound repair. These cells
included mast cells, neutrophils, and platelets. The materials
released from platelets exhibited the highest activity . We dem-
onstrate that the chemoattractant present in this exudate fluid
is the platelet-derived growth factor(PDGF) . Since this 30,000-
dalton, heat-stable basic protein is a potent mitogen in serum
for fibroblasts (17-19), we tested other growth factors for their
ability to stimulate chemotaxis. No other growth factors were
found to be active for these cells, indicating that PDGF is
unique among mitogens in this respect . This has led us to
postulate that, in the wound, PDGF aids tissue repair both by
attracting fibroblasts into the clot and by inducing their sub-
sequent proliferation .
MATERIALS AND METHODS
Cell Cultures and Assay of Chemotaxis
Most experiments were carried out using a human fetal skin fibroblast strain,
CRL 1475, obtained from the American TypeCulture Collection, Rockville, Md.
For comparison, cells from five strains of human skin fibroblasts from adults
were also used (kind gifts from Drs . B . McCoyandK . Cohen, Division ofPlastic
Surgery, Medical College of Virginia, Richmond, Va .) . All cells were grown in
Dulbecco's modification of Eagle's medium (DMEM) containing 5% (vol/vol)
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subcultured weekly, and confluent cultures were used in chemotaxis assays since
preliminary experiments showed that cells from these were more responsive than
cells from less dense cultures.
Peritoneal exudates were induced in rabbits and used as source of polymor-
phonuclear leukocytes as described earlier (20). Cells were washed twice in
DMEM containing 1 mg/ml of bovine serum albumin (DMEM-BSA ; Reheis
Chemical Co., Phoenix, Ariz .), suspended in the same medium, and incubated
with 10' 5 M formylmethionylleucylphenylalanine (FMLP) (Peninsula Labora-
tories, San Carlos, Calif.) to induce a release reaction (21) . Cells were spun down
at 800 g and the supernatant was then tested for chemotactic activity. Controls
consisted of supernatants from cells incubated without FMLP, and FMLP
incubated without cells .
Platelets were obtained from the Blood Bank, National Institutes of Health
(NIH) (Bethesda, Md .). The platelets were suspended in DMEM-BSA, washed
free of plasma by centrifugation at 1,200 g for 15 min at room temperature,
adjusted to a concentration of 2.5 x 10 1° platelets/ml, and exposed to 1 U/ml of
human thrombin (Sigma Chemical Co ., St. Louis, Mo .) at 37'C for 5min . After
aggregation, the mixture was centrifuged, and the supernatant was used for
chemotaxis assay . Controls consisted ofsupernatants incubatedwithout thrombin
and thrombin incubated without cells .
Rat mast cell media were kindly donated by Dr . M. Kaliner, Laboratory of
Clinical Investigation, National Institute ofAllergy and Infectious Diseases,NIH.
The mast cells were isolated and purified as previously described (22), and
exposed to compound 48/80 at 5 pg/ml for 5 min to activate granule release
reaction from cells suspended in DMEM-BSA at 105 cell/ml . The histamine
content of the supernatant fluid showed that a release reaction had taken place.
The supernatants were used for chemotaxis assays. Controls were supernatants
from cells incubated without 48/80, and 48/80 incubated without cells .
The migration of fibroblasts was assayed as described by Postlethwaite et al.
(10). The fibroblasts were detached from the tissue culture flasks with 0.1% (wt/
vol) trypsin (Worthington Biochemical Corp ., Freehold, N. J .) in phosphate-
buffered saline at 37°C, using as short a time as possible, usually 3 min or less,
to avoid excessive exposure to trypsin . The cells were suspended in DMEM
containing0.5% (wt/vol) bovine pancreatic trypsin inhibitor (Aprotinin ; Boehrin-
ger Mannheim Biochemicals, Indianapolis, Ind.), washed in DMEM containing
I mg/ml ofDMEM-BSA, and suspended in DMEM-BSA. Aportion ofthe cells
were counted with a Coulter counter, and the cell concentration was adjusted to
3x 105 cells/ml . Attractant solutions (0 .2 ml) were pipetted into bottom wells of
Boyden blind-well chambers (type 200-312 ; Neuroprobe, Bethesda,Md .), and 8-
,um-pore-size polycarbonate (Nuclepore, Pleasanton, Calif.) filters coated with
gelatin were placed above them. The chambers were assembled and 0.8 ml ofthe
cell suspension was pipetted into the top compartment of each chamber. The
chambers were incubated for4h at 37'C in a humidified atmosphere ofair/5%
COs . At the end of the assay, the filters were removed and the cells were fixed
and stained with Diff-Quick (Scientific Products, Columbia, Md.) . The filter was
rinsed twice with waterand placed on a microscope slide, with the lower surface
facing the slide . Cells which did not migrate through the filterwere wiped offthe
upper surface with a cotton swab . Migrated cells were counted in consecutive
microscope fields along the diameter ofthe filter, covering a total area of I mm'.
Assays were run in triplicate.
Attachmentof cells was determined by counting numbers of cells on the upper
surface of filters from quadruplicate chambers .
Sources of Growth Factors
Purified PDGF and platelet extractswith known mitogenic activities (19) were
gifts fromC . D. Scher andC . D. Stiles (Sidney Farber Cancer Institute, Boston,
Mass .) . This growth factor was stable to heating (100'C for 10 min) and was
homogeneous by PAGE. PDGF was inactivated by trypsin and by exposure to
sulfhydryl reagents . A mitogenic unit (U) of PDGF is defined as that which
induces DNA synthesis in 50% of confluentBALB/c 3T3 (clone A31) cells when
they are cultured in 5% plasma (19) . Partially purified PDGF, epidermal growth
factor (EGF), bovine fibroblast growth factor (FGF), and nerve growth factor
(NGF) were purchased from Collaborative Research (Waltham, Mass.). Zinc-
free porcine insulin was obtained from Elanco Products (Indianapolis, Ind.) . On
the generation of data in all tables and figures, purified PDGF, not activated
platelet supernatants, was used .
Assay for Growth Factor-induced DNA
Synthesis in Fibroblast Cultures
Induction ofDNA synthesis inCRL 1475 fibroblasts by growth factors was
assayed by measuring the incorporation of['H]thymidine (23). Cells were plated
in multiwell tissue culture plates at 6,000 cells/0.32-cm' well in 0.3 ml ofDMEM
plus 5% fetal calf serum . After 2 d, cells were washed twice with DMEM without
serum and were incubated in DMEM without serum for an additional 12 h.
Growth factors, dissolved in DMEM, were then added to the cells. After 16 h,
[methyl-''H]thymidine (25 Ci/mmol, Amersham Corp ., Arlington Heights, Ill.)
wasadded to a final concentration of 1 ttCi/0 .3 ml in each well without removing
the growth factor. The incorporation of [''H]thymidine was measured 24 h later
by detaching the cells with trypsin solution and harvesting the cells on filters
(Whatman 934-AH glass microfiber filters) using a cell harvester (Brandel,
Rockville, Md.). The radioactivity on the filters was determined by scintillation
counting .
Inhibition of Synthesis of DNA, RNA,
and Protein
Fibroblasts were suspended as described above, and hydroxyurea (Sigma
Chemical Co .), azidocytidine (2'-azido-2'-desoxycytidine ; Boehringer-Mannheim
Biochemicals), or actinomycinD (Sigma Chemical Corp.) wasadded to give the
specified final concentrations. The cell suspensions were incubated at 37'C in a
humidifiedatmosphere of5%C02/air for 30min. Controlcellswere preincubated
without additions . The cells were transferred to chemotaxis chambers and their
migration was tested in response to 0.5 U of PDGF/ml in the lower well . To
avoid gradients ofinhibitors, the lower well alsocontained the same concentration
of inhibitor that was present in the cell suspension . Viability of cells was
determined at the termination of the chemotaxis assay using the trypan blue
exclusion test in a parallel experimentwith the same cell suspensions . The effects
of the inhibitors on macromolecular synthesis were determined in parallel mul-
tiwell cultures . Inhibition of protein synthesis by cycloheximide was monitored
by measuringincorporation of t -[4,5-''H]leucine (76Ci/mmol ; Amersham Corp .);
inhibition ofRNA synthesis by actinomycin Dby measuring [5,6-'H]uridine (40
Ci/mmol; Amersham Corp .) incorporation; and inhibition ofDNA synthesis by
hydroxyurea and azidocytidine by measuring [methyl-''H]thymidine incorpora-
tion .
RESULTS
In preliminary studies, we assayed materials secreted by mast
cells, neutrophils, and platelets for their chemotactic activity
toward fibroblasts . There was no detectable chemotactic activ-
ity in the supernatant fluids of rat mast cells which had been
activated to release their granules by using compound 48/80 .
Chemotactic activity for fibroblasts was observed in the super-
natants of rabbit polymorphonuclear cells that had been acti-
vated to secrete materials by means ofFMLP . The activity was
210% of the level observed in controls . An even stronger
chemotactic response (400% of control) was seen by using
supernatant fluid from platelets that had been aggregated with
thrombin (24) . This activity exceeded the maximal response of
fibroblasts to fibronectin and was therefore likely to be distinct
from that of fibronectin.
Since PDGF is present in the a-granules of platelets (25), it
was possible that a significant fraction of the chemotactic
activity in the supernatant from stimulated platelets could be
accounted for by this growth factor . We therefore compared
the chemotactic activity in the material released from platelets
with that of purified PDGF . A strong chemotactic response
was obtained with purified PDGF (Fig. 1), although, at con-
centrations >1 U/ml, chemotaxis was reduced while ['H]thy-
midine incorporation remained maximal. At concentrations
that were mitogenically equivalent, the chemotactic response
obtained with the platelet supernatant was equal to that ob-
tained with purified PDGF (data not shown) . We were, there-
fore, able to replace the supernatant from stimulated platelets
with PDGF . These studies indicate that PDGF is a potent
chemotactic factor for fibroblasts present in the platelet fluids .
While the chemotactic response of the cells was reduced at
high levels of PDGF, similar requirements for optimal- levels
of attractants have been observed previously with other cells
and other attractants (26) . The inhibition is usually attributed
to a loss of the concentration gradient guiding the direction in
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585which the cells migrate and to a deactivation of the cells due
to "down regulation" of the receptors for the attractant .
Evidence that PDGF was chemotactic rather than just che-
mokinetic was obtained by a "checkerboard" analysis (27, 28) .
Here, different concentrations of PDGF added below and
above the filter in the Boyden chamber were varied in a
systematic manner to generate various gradients ofthe material
(Fig. 2) . Migration of the cells across the filter occurred when-
ever the concentration ofPDGF in the lower compartment was
greater than that in the upper chamber, indicating that migra-
tion occurs along a concentration gradient ofPDGF. It should
be noted that the Zigmond-Hirsch (27) procedure for deter-
mining chemotactic motility measures the distance traveled by
the leading front of cells within a micropore filter for a given
period of time. Here, we are measuring numbers of cells that
have crossed the width of the filter during a given period of
time . Our results, however, are consistent with what would be
expected for cells responding to a gradient of attractant (27) .
It was possible that the PDGF had bound to the membrane
filter separating the two compartments ofthe Boyden chamber
and that the cells were migrating along a gradient of immobi-
lized PDGF, a process known as haptotaxis (29) . To test for
haptotaxis, filters were incubated with various concentrations
of PDGF to allow binding to occur and were then placed in
the Boyden chamber . No significant migratory response by
fibroblasts was observed when the filters were exposed to
PDGF before assay compared to their responses when similar
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FIGURE 1 Comparison of migratory (") and mitogenic (O) re-
sponses of human skin fibroblasts (CRL 1475) to purified platelet-
derived growth factor. The responses, which are expressed as per-
centage of the maximal response, are given on the ordinate . The
maximal migratory response to PDGF was 345 ± 25 cells/mm' and
the background in the absence of attractant was 113 ± 8 cells/mm'
of filter surface . Each point is the average of triplicate values.
Number of experiments performed was three .
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FIGURE 2
￿
Migratory responses of fibroblasts to varied gradients of
partially purified PDGF . Gradients were created by adding PDGF
solutions of given concentrations to wells below filter and to cell
suspensions to make given final concentrations. The values in the
checkerboard are the numbers of migrated cells ± SEM per mm2
area of filter. Each point is the average of triplicate values . Number
of experiments performed was four .
concentrations of PDGF were added to the lower chamber
(Table I) . These experiments indicate that migration of the
fibroblasts in response to PDGF is the result ofa true chemo-
tactic response and not to haptotaxis.
As noted previously, PDGF is a potent mitogen for fibro-
blastic cells, and the accumulation ofcells on the lower surface
of the filter could be due to proliferation . However, the tim,--
course of the chemotactic response (2-4 h) suggests that cell
proliferation is not involved (17, 30). In addition, hydroxyurea
and azidocytidine had no effect on the migratory response of
the cells at concentrations which inhibited DNA synthesis by
93-97% (Table II) . In contrast, actinomycin D and cyclohex-
imide inhibited the chemotactic response ofthe cells in a dose-
TABLE I
Migration of fibroblasts on Filters Preincubated in the
Presence ofPDGF Gradients
* Filters were preincubated at 37°C in the chemotaxis chambers in the
presence or absence of partially purified PDGF in the lower well for 30 min.
After incubation, the medium above filter was suctioned off, the filter was
removed and washed in three changes of DMEM-BSA, and finally 5 ml of
DMEM-BSA was forced through the filter using a syringe and a Millipore
filtration unit. Filters were used immediately in chemotaxis assays where no
PDGF was added to lower well . Number of experiments performed was
four .
TABLE- II
Effect of Inhibiting Synthesis of Protein, RNA, or DNA on
Fibroblast Chemotaxis to PDGF
* Values give migratory responses expressed as percent of response to 0.5 U/
ml of partially purified PDGF observed in the absence of inhibitors .
$ Values give incorporation of specified radiolabeled substance as percent of
incorporation in the absence of inhibitors. Each point is the average of
triplicate values, the SEM of which did not exceed 15%. Number of experi-
ments performed was three .
0.1 Ag/ml
5.0 ttg/m1
94
42
16
3
20 .0 Ag/m 1 8 1.5
[3H]Uridine incor-
poration$
Actinomycin D
0.1 wg/ml 90 35
1 .0 jug/ml 50 12
10 .0 hg/ml 6 11
[3H]Thymidine in-
corporation$
Hydroxyurea
0.1 mm 93 100
1 .0 mm 116 46
5.0 mM 125 7
Azidocytidine
0.1 mm 70 6
0.5 mM 100 6
1 .5 mM 123 3
PDGF
Migratory
PDGF present during
preincubation only*
responses
PDGF present dur-
ing chemotaxis assay
U/ ml cells/mm' ± SEM
0 84±36 110±17
0.1 110 ± 10 134 ± 8
0.5 129 ± 19 232 ± 30
[3 H]Leucine in-
Inhibitor Chemotaxis* corporation$
% of control %of control
Cycloheximidedependent manner. These data indicate that the chemotactic
response of the fibroblasts require RNA and protein synthesis
but not DNA synthesis.
Next, several other growth factors were tested for chemotac-
tic activity (Fig. 3) and for their ability to stimulate thymidine
incorporation into cultured skin fibroblasts (data not shown) .
At 0 .5 Fig/ml, fibroblast growth factor, epidermal growth factor,
insulin, and PDGF all stimulated DNA synthesis, while nerve
growth factor had no effect even at 5 tLg/ml . Ofthese materials,
only PDGF showed strong chemoattractant activity (Fig. 3) .
These results indicate that chemotactic activity is not a general
property of mitogens .
Previous studies on leukocytes have shown that preincuba-
tion with a chemoattractant can prevent the subsequent chem-
otactic response to itself and to other attractants (26, 31, 32) .
To determine whether PDGF has this deactivating effect, cells
prepared by the usual methods were divided into two groups
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Comparison of growth factors as fibroblast chemoattrac-
tants . Partially purified preparations of platelet-derived growth fac-
tor (PDGF), epidermal growth factor (EGF), fibroblast growth factor
(FGF), nervegrowth factor (NGF), and a pure preparation of insulin
were dissolved in DMEM containing 1 mg/ml of bovine serum
albumin to give the specified concentrations and were tested for
chemotactic activity in Boyden blind-well chambers. At these con-
centrations, the growth factors, except NGF, stimulate incorporation
of [3H]thymidine in fibroblasts (not shown) . The activities of the
growth factors (Collaborative Research Corp .) are as follows : 1 U of
PDGF = 3 pg/ml, 1 U of EGF = 100 ng/ml, and 1 U of FGF = 33 ng/
ml . The open bar shows the migration in the absence of added
growth factor . Each point is theaverage of triplicate values . Number
of experiments performed was four.
TABLE III
Effect of Preincubation of Fibroblasts with PDGF on Their
Subsequent Chemotaxis to PDGF
Migratory responses, cellslmm z
* After trypsinization, cells were preincubated for 30 min at 37 °C in DMEM
supplemented with 0.1% BSA. The cells after washing were resuspended in
the same medium and assayed for chemotaxis as in Methods . Number of
experiments performedwas three. Partially purified PDGF was used in both
the preincubation and attractant solutions .
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FIGURE 4 Migratory responses of six strains of human skin fibro-
blasts to partially purified PDGF . CRL 1475 is the fetal line used in
all other experiments . The other strains are from adults. Each point
is theaverage of triplicate values . Numberof experimentsperformed
was three .
which were preincubated for 30 min either with 2 U/ml of
PDGF or with control medium . The cells were then washed
and assayed for their chemotactic responsiveness to either
PDGF or fibronectin . As seen in Table III, the response of the
pretreated cells to both attractants was greatly reduced com-
pared with the controls . This indicated that the fibroblasts, like
leukocytes, are deactivated by their own attractants, suggesting
that there may be similarities in the regulatory mechanisms of
migration in both cell types .
To exclude the possibility that only fetal cells respond chem-
otactically to PDGF, we tested fibroblasts from adult human
skin and found that they also respond to PDGF in a dose-
dependent manner (Fig. 4) .
Our studies show that platelets release a potent chemoattractant
for fibroblasts . Similar chemotactic activity is observed with
purified PDGF . Since PDGF is the major mitogenic factor in
the platelet-derived fluids, we compared the mitogenic and
chemotactic activities in the platelet fluids with those of the
purified material. These studies showed that the chemotactic
activity of platelet fluids can be attributed to PDGF. PDGF
over a wide concentration range stimulated the incorporation
of (3H]thymidine intoDNA, whereas chemotaxis was inhibited
at higher concentrations of PDGF . PDGF is also a chemoat-
tractant for smooth muscle cells (33) but not for endothelial
cells or polymorphonuclear leukocytes (Seppa et al ., manu-
script in preparation) . In this regard, there is a correlation
between the chemotactic responsiveness of cells and their abil-
ity to respond mitogenically . Both responses presumably de-
pend on the presence of receptors for PDGF .
Results ofexperiments in which fibroblasts were treated with
inhibitors of DNA, RNA, and protein synthesis demonstrate
that the response of the cells to PDGF depends upon the
continuous synthesis ofprotein. In this regard, fibroblasts differ
from leukocytes in which chemotaxis occurs evenwhen protein
synthesis (34) or RNA synthesis (E. Schiffman, unpublished
results) is blocked . In contrast, DNA synthesis is not required
for chemotaxis . Results with hydroxyurea and azidocytidine,
furthermore, indicate that the proliferation of cells is not
responsible for increased migration in the presence ofPDGF .
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Conditions of
preincubation*
PDGF
(2 U/ml)
Attractants
Fibronectin
(20 pg/ml) None
PDGF, 2 U/ml in 72 ± 18 67 ± 11 20 1 5
DMEM-BSA
DMEM-BSA 318 ± 15 252 ± 12 81 ± 12In addition, the time of assay (4 h) is shorter than the time
required to detect a mitogenic response (30 h) .
The loss of responsiveness ofthe fibroblastswhen pretreated
with an attractant is similar to what has been reported previ-
ously for neutrophils (26, 31, 32) . It is possible that the loss of
response, or deactivation, resembles the "down regulation"
observed with various peptide hormones and involves loss of
surface receptors either by a direct effect or as a secondary
consequence of cytoskeletal changes .
Various peptide growth factors, including EGF, FGF, insu-
lin, and NGF, were not active in thechemotaxis assay although
all but NGF are mitogenic for fibroblasts . The experiments
reported here do not support the possibility that mitogenicand
chemotactic activities of PDGF are directly related although
both responses could involve identical receptors . The concen-
trations ofPDGF required forchemotaxis and mitogenesis are
similar . However, the cells respond in chemotaxis assays to a
gradient ofPDGF, where the indicatednominal concentration
is present only in the lower compartment of the chamber. The
cells, therefore, respond chemotactically to a concentration of
PDGF lower than that required for mitotic activity .
The responses of fibroblasts to PDGF may be significant in
wound repair . When platelets aggregate early in clot formation
they release PDGF, which may recruit fibroblasts into the
wound area . The mitogenic activity ofPDGF may then cause
a rapid proliferation of fibroblasts . Subsequently, these cells
wouldproduce collagen and other materials necessary to repair
the wound . In this context, PDGF may be considered a wound
hormone . When such a response occurs inappropriately, it
could lead to fibrosis .
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